Skip to Main content Skip to Navigation
Journal articles

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

Abstract : Clinical and translational research has played a major role in advancing our understanding of pulmonary hypertension (PH), including pulmonary arterial hypertension and other forms of PH with severe vascular remodelling (e.g. chronic thromboembolic PH and pulmonary veno-occlusive disease). However, PH remains an incurable condition with a high mortality rate, underscoring the need for a better transfer of novel scientific knowledge into healthcare interventions. Herein, we review recent findings in pathology (with the questioning of the strict morphological categorisation of various forms of PH into pre- or post-capillary involvement of pulmonary vessels) and cellular mechanisms contributing to the onset and progression of pulmonary vascular remodelling associated with various forms of PH. We also discuss ways to improve management and to support and optimise drug development in this research field.
Complete list of metadatas

https://www.hal.inserm.fr/inserm-02612658
Contributor : Christophe Guignabert <>
Submitted on : Tuesday, May 19, 2020 - 1:38:48 PM
Last modification on : Monday, July 20, 2020 - 1:08:01 PM

Links full text

Identifiers

Collections

Citation

Marc Humbert, Christophe Guignabert, Sébastien Bonnet, Peter Dorfmüller, James Klinger, et al.. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. European Respiratory Journal, European Respiratory Society, 2019, 53 (1), pp.1801887. ⟨10.1183/13993003.01887-2018⟩. ⟨inserm-02612658⟩

Share

Metrics

Record views

45